Skip to Content Skip to Search

GSK and Help for Heroes partner to support the rehabilitation of wounded servicemen and women in the UK

GSK and Help for Heroes today announced a new partnership to help support injured British armed forces personnel successfully transition back into civilian life. The partnership will focus on the creation of a specialist 'Wellness Centre' at Tedworth House, a Personnel Recovery and Assessment Centre located in Wiltshire.

Issued: London UK

GSK and Help for Heroes today announced a new partnership to help support injured British armed forces personnel successfully transition back into civilian life. The partnership will focus on the creation of a specialist 'Wellness Centre' at Tedworth House, a Personnel Recovery and Assessment Centre located in Wiltshire.

As part of its programme of charitable support in the UK, GSK has pledged to donate £1 million to Help for Heroes over 5 years to be used towards the initial construction and the ongoing running of the new Phoenix Wellness Centre. At full capacity the Centre, due to open in mid-2012, will deliver health, sport and exercise programmes to help over 1,000 servicemen and women each year achieve their individual physical and psychological recovery goals. GSK will also provide pro-bono support in the form of know-how and expertise and will offer GSK employees volunteering opportunities with Help for Heroes as part of a broader partnership between the two groups.

GSK is committed to promoting health and well-being in the communities in which it operates and supports a wide variety of innovative, dynamic charities that help deliver this, such as Help for Heroes.

Andrew Witty, CEO of GSK said: "This new partnership with Help for Heroes will make state of the art rehabilitation facilities available to wounded servicemen and women who deserve our support. GSK is committed to playing its part in helping to improve the health and well-being of communities and we look forward to seeing the completion of the Wellness Centre and to sharing our expertise with Help for Heroes through a long term partnership."

Bryn Parry, CEO and Co-Founder of Help for Heroes said: that we have GSK Help for Heroes are thrilled to be partnering with GSK. They have already donated an amazing sum of money for which we are hugely grateful and have pledged to continue their support into the future. This support will be invaluable because although the guys and girls are young now, they will grow old and we need to be theretosupport themfor life. Knowing GSK's support for the next few years really is fantastic."

Once constructed, the Wellness Centre at Tedworth House will stretch to 700m2 and will house a gymnasium with specialist equipment. It will provide individually tailored programmes and will facilitate delivery of bespoke physical recovery programmes. The Wellness Centre will also act as central hub for organising sports, adventure training and additional recreational activities such as canoeing, climbing, skiing and archery. A centre of excellence in sports nutrition and physiology, with onsite specialists available to provide support tailored to an individual's need.


GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com

About Help for Heroes

  • Thanks to the fantastic British Public, Help for Heroes (H4H) has raised over £120m since its launch in October 2007./
  • All over the country, people are baking cakes, shaving heads, parachuting, walking, hiking, cycling and much much more to raise money for our heroes./
  • H4H does not seek to criticise or be political. Our goal is to assist and work closely with the Royal Navy, Army and Royal Air Force to provide support where it is most needed.
  • To date, all monies raised for H4H have spent or allocated on the direct, practical support of our Servicemen and women who are wounded, injured or have become sick while in the service of our country, to include support and assistance to their families when appropriate. For information on how we spend your money, visit www.helpforheroes.org.uk/how_we_spend.html
  • H4H has funded a variety of projects including the £8m Rehabilitation Complex at Headley Court, a new £3.5m treatment centre for Combat Stress, £1m for adaptive adventure training through the Battle Back programme and the creation of a £6m Quick Reaction Fund to support individuals in need.
  • In February 2010, H4H announced its lead role in the creation of five regional Personnel Recovery Centres (PRCs), which provide, in partnership with the MOD, The Royal British Legion and other Service charities, on-going training and support for the wounded after Headley Court. H4H has committed to raising £150 million to build and run the centres in what is believed to be the largest contribution in British military history. Locations of the PRCs are Edinburgh, Colchester, Catterick, Tidworth and Plymouth.

GlaxoSmithKline Enquiries:

 

 

 

UK Media enquiries:

David Mawdsley

+44 (0) 20 8047 5502

(London)

 

Stephen Rea

+44 (0) 20 8047 5502

(London)

 

Sarah Spencer

+44 (0) 20 8047 5502

(London)

 

David Daley

+44 (0) 20 8047 5502

(London)

 

 

 

 

US Media enquiries:

Kevin Colgan

+1 919 483 2839

(North Carolina)

 

Mary Anne Rhyne

+1 919 483 2839

(North Carolina)

 

Sarah Alspach

+1 919 483 2839

(Washington, DC)

 

Jennifer Armstrong

+1 919 483 2839

(Philadelphia)

 

 

 

 

Analyst/Investor enquiries:

Sally Ferguson

+44 (0) 20 8047 5543

(London)

 

Tom Curry

+ 1 215 751 5419

(Philadelphia)

 

Gary Davies

+ 44 (0) 20 8047 5503

(London)

 

Ziba Shamsi

+ 44 (0) 20 8047 3289

(London)

 

Jeff McLaughlin

+ 1 215 751 7002

(Philadelphia)

 

Help for Heroes Enquiries:

 

 

 

Communications Team:

prcomms@helpforheroes.org.uk
+44 (0)1725 514 276

(London)

 

 

GlaxoSmithKline cautionary statement regarding forward-looking statements
Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK's operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2010.